產(chǎn)品搜索
相關(guān)文章
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- 【連載-企業(yè)參考品】乳腺癌的PCR和NGS參考品的選擇
- NIPT標(biāo)準(zhǔn)品-助力無創(chuàng)產(chǎn)前檢測(cè)
- PLoS ONE:科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- 一個(gè)蛋白竟可同時(shí)影響乳腺癌和淋巴癌的形成與擴(kuò)散
- ctDNA液體活檢診斷標(biāo)準(zhǔn)品
- FLT3標(biāo)準(zhǔn)品簡(jiǎn)介
- IL4藥物細(xì)胞篩選模型
- 細(xì)胞株的表達(dá)量越高越好嗎?
- NGS檢測(cè)血液腫瘤基因
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73233c-Kit W557_K558del/BaF3

- 詳細(xì)內(nèi)容
CBP73233 | |
I. Introduction | |
Cell Line Name: | c-Kit W557_K558del/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
KIT W557del results in the deletion of an amino acid in the juxtamembrane domain (exon 11) of the Kit protein at amino acids 557 (PMID: 12918066). W557del has not been characterized, however similar Kit exon 11 deletions are activating (PMID: 9438854, PMID: 9797363), and therefore, is predicted to lead to a gain of Kit protein function . | |
III. Representative Data | |
1. WB of c-Kit W557_K558del/BaF3 | |
2.Sanger of c-Kit W557_K558del/BaF3 | |
3. Anti-proliferation assay Figure 3. CTG Proliferation Assay of BaF3 c-KIT W557_ K558del (C2). | |
|